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Abstract 
Background: Naturally occurring polyphenolic compounds from fruits, particularly from blueberries, have been 
reported to be significantly involved in cancer chemoprevention and chemotherapy. Biotransformation of blueberry 
juice by Serratia vaccinii increases its polyphenolic content and endows it with anti‑inflammatory properties.
Methods: This study evaluated the effect of a polyphenol‑enriched blueberry preparation (PEBP) and its non‑fer‑
mented counterpart (NBJ), on mammary cancer stem cell (CSC) development in in vitro, in vivo and ex vivo settings. 
Effects of PEBP on cell proliferation, mobility, invasion, and mammosphere formation were measured in vitro in three 
cell lines: murine 4T1 and human MCF7 and MDA‑MB‑231. Ex vivo mammosphere formation, tumor growth and 
metastasis observations were carried out in a BALB/c mouse model.
Results: Our research revealed that PEBP influence cellular signaling cascades of breast CSCs, regulating the activity 
of transcription factors and, consequently, inhibiting tumor growth in vivo by decreasing metastasis and controlling 
PI3K/AKT, MAPK/ERK, and STAT3 pathways, central nodes in CSC inflammatory signaling. PEBP significantly inhibited 
cell proliferation of 4T1, MCF‑7 and MDA‑MB‑231. In all cell lines, PEBP reduced mammosphere formation, cell mobil‑
ity and cell migration. In vivo, PEBP significantly reduced tumor development, inhibited the formation of ex vivo mam‑
mospheres, and significantly reduced lung metastasis.
Conclusions: This study showed that polyphenol enrichment of a blueberry preparation by fermentation increases 
its chemopreventive potential by protecting mice against tumor development, inhibiting the formation of cancer 
stem cells and reducing lung metastasis. Thus, PEBP may represent a novel complementary alternative medicine 
therapy and a source for novel therapeutic agents against breast cancer.
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Background
Life-style changes significantly contribute to cancer 
prevention and are considered an important paradigm 
in translational medicine [1]. For example, a dietary 
intervention showed that a few months of following a 
Mediterranean diet are sufficient to favorably modify 
the metabolic/endocrine characteristics of breast cancer 
survivors [2]. In fact, breast cancer patients are among 
the highest users of integrative medicine in conjunction 
with conventional oncology care [3]. Currently, cancer 
preventive phytochemicals are receiving increasing atten-
tion regarding their impact on Cancer Stem Cell (CSC) 
self-renewal pathways [4]. In line with these reports, our 




*Correspondence:  chantal.matar@uottawa.ca 
1 Nutritional Sciences Program, Faculty of Health Sciences, University 
of Ottawa, R2057 Roger Guindon Hall, 451 Smyth Road, Ottawa, ON K1H 
8M5, Canada
Full list of author information is available at the end of the article
Page 2 of 12Vuong et al. J Transl Med  (2016) 14:13 
CSCs by fermented blueberry preparation, named Poly-
phenols-Enriched Blueberry Preparation (referred here-
after as PEBP), supports diet-mediated targeting of CSCs. 
The chemopreventive effects of blueberry polyphenolics 
on breast cancer are well-known [5, 6]. For example, 
phenolic extracts from European blueberry were shown 
to inhibit proliferation and induce apoptosis in breast 
cancer cells [7]. Therefore, increasing the phenolic con-
tent of blueberry might enhance its anticancer properties 
and reduce its metastatic potential. Indeed, biotransfor-
mation of blueberry juice with a novel strain of bacteria 
isolated from the blueberry flora increases its phenolic 
content and antioxidant activity [8].
CSCs, a highly tumorigenic cell subtype, are emerging 
as key drivers of cancer [9, 10]. CSCs in breast cancer 
have been identified as CD44+/CD24low phenotype and 
are able to grow as spheres named, in this case, mammos-
pheres [11, 12]. Interleukin 6 (IL-6) and its major effec-
tor, the signal transducer and activator of transcription 
3 (STAT3), are part of an important inflammation-asso-
ciated pathway in malignancies, and are highly involved 
in CSC development and progression [13]. STAT3 has 
been recently recognized as a key therapeutic target to 
reduce tumor growth [14] and metastasis [15] in differ-
ent types of cancer. The persistent self-renewal observed 
in CSCs was reported to be epigenetically controlled in 
the IL-6/STAT3/phosphatidylinositol 3-kinase (PI3K) 
signaling pathway [16]. STAT3 with PTEN is part of 
the positive feedback loop that underlies the epigenetic 
switch that links inflammation to cancer. Thus, preven-
tion or inhibition of deregulation in the PI3K/STAT3/
PTEN signaling pathway could be beneficial for the treat-
ment and better outcome of breast cancer. Several signal 
transduction pathways, such as the extracellular-signal-
regulated kinase/mitogen-activated protein kinase (Erk/
MAP) pathway and PI3K pathway have been implicated 
in mammary carcinogenesis [17].
Moreover, members of the mitogen-activated protein 
kinase (MAPK) pathways have been well studied for their 
role in controlling cellular responses to the environment 
and in regulating gene expression, cellular growth and 
apoptosis in cancer [18, 19]. The extracellular signal-reg-
ulated kinases (ERKs)-1/2 were linked to cell prolifera-
tion and survival, whereas the stress-activated MAPKs, 
p38 and c-Jun N-terminal kinase (JNK), were connected 
to apoptosis [20]. Controlling MAPK pathways was 
shown to impact CSC-promoting IL-6 and modify CSC-
like behavior [21].
Different studies have shown that the fermentation 
of PEBP greatly increased its antioxidant potential [8, 
22] and endowed it with novel anti-inflammatory [23], 
antidiabetic [24, 25] and other biological activities [23]. 
Importantly, the anti-inflammatory effects of PEBP 
seemed to be connected to IL-6 related pathways, as 
demonstrated by decreasing hyperglycemia, activating 
AMPK pathways and mimicking Metformin metabolic 
effects [24]. Additionally, our studies have revealed that 
PEBP increases adiponectin secretion [24], probably by 
counteracting reactive oxygen species [26] and inhibiting 
the pro-inflammatory cytokines [27]; two mechanisms 
that contribute to the inflammatory response. Indeed, 
inflammation is linked to obesity, diabetes and cancer 
[28]. The goal of this study was to investigate the anti-
carcinogenic effects of polyphenol-enriched blueberry 
preparation (PEBP) on breast cancer stem cell develop-
ment in cell models and in  vivo, as well as to study the 




Mature lowbush blueberries (Vaccinium angustifolium 
Ait.) were purchased from Cherryfield Foods Inc. (Cher-
ryfield, ME) as fresh and untreated fruits. Blueberry juice 
was extracted by blending the fruit (100  g) in a Braun 
Type 4259 food processor. The fruit mixture was then 
centrifuged at 500×g for 10 min to remove insoluble par-
ticles. The resulting juice was sterilized using 0.22  µm 
Express Millipore filters (Millipore, Etobicoke, ON).
Serratia vaccinii bacteria were cultured as previously 
described [8]. Blueberry and polyphenol-enriched blue-
berry preparation have been partially characterized else-
where [8, 29].
Cell culture
Murine 4T1, a 6-Thioguanine resistant cell line, human 
MCF-7 and human MDA-MB-231 cell lines were 
obtained from American Type Cell Collection (ATCC; 
Chicago, IL, USA). ATCC authenticated the human cell 
lines by using short tandem repeat profiling and the mice 
cell line was confirmed to be from mice by cytochrome C 
oxidase 1 gene assay. MCF-7 cells were cultured in MEM, 
4T1 and MDA-MB-231 in RPMI-1640, media containing 
FBS (10  %, v/v) (ATCC), penicillin (100 µU/ml), strep-
tomycin (100  µg/ml) (Sigma-Aldrich, Oakville, ON) at 
37 °C in a humidified atmosphere with 5 % CO2.
Cell viability
Cell viability was assessed by water soluble tetrazolium 
salts (WST-1) and Lactate Dehydrogenase (LDH) assays 
(Roche, Laval, QC). After a 24 h treatment, supernatants 
were collected for LDH assay following the manufactur-
er’s instructions. The absorbance was measured with the 
μ-Quant plate reader (Bio-Tek, Winooski, VT) [30].
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Cell motility
Cells were plated in a six-well plate at density of 1 × 106 
cells/0.2  ml/well and allowed to form a confluent mon-
olayer for 24 h. The monolayer was then scratched with 
a pipette tip, washed with RPMI-1640 to remove floating 
cells, and photographed (time 0). The cells were treated 
with NBJ or PEBP for 24  h. The cells were then photo-
graphed again at three randomly selected sites per well. 
Cell motility was expressed as a percent of the surface 
area covered by migrating cells compared with time 0 
[30].
Cell invasion
The cell invasion assay was performed on a polyethyl-
ene terephthalate (PET) membrane (8  µm pore size) in 
a Tissue Culture (TC) insert (BD biosciences, Missis-
sauga, ON) according to the manufacturer’s instructions. 
In short, cells are incubated in the superior chamber for 
24  h. The insert is then transferred to a new plate con-
taining HBSS supplemented with 4 µg/ml of Calcein AM 
for 1 h. The intensity of the fluorescence is measured and 
is expressed as a ratio of the control well without treat-
ment [31].
Mammospheres formation
Adherent cells were detached by trypsin and single cells 
were counted using the Countess automated cell counter 
(Invitrogen, Burlington, ON). For tumor tissue, approxi-
mately 0.05 g of each tumor was minced and dissociated 
in RPMI-1640 media containing 300 U/ml collagenase 
(Sigma), and 100 U/ml hyaluronidase (Sigma) at 37 °C for 
2 h. The cells were sieved sequentially through a 100 µm 
and a 40 µm cell strainer (BD Biosciences) to obtain a sin-
gle cell suspension, and counted in a hemocytometer.
Single cells were plated in ultralow attachment 96-well 
plates (Costar) at 103 cells/0.2  ml/well, in the presence/
absence of PEBP and NBJ, in DMEM-F12 (Invitrogen), 
supplemented with 10 ng/ml EGF, 20 ng/ml bFGF, 5 µg/
ml insulin, 1 mM sodium pyruvate, 0.5 µg/ml hydrocor-
tisone, and penicillin/streptomycin (0.05 mg/ml) (Sigma) 
[16]. Cells grown in these conditions as non-adher-
ent spherical clusters of cells or mammospheres were 
counted after 4–7 days.
IL‑6 determination
BD OptEIA Mouse IL-6 ELISA sets (BD Biosciences) 
were used to measure extracellular IL-6 produc-
tion by mammospheres following the manufacturer’s 
instructions.
Western blot analysis
Cells in mammospheres formation conditions were col-
lected and lysed after 1, 2, 6 and 24  h treatment with/
without PEBP and NBJ. Cell lysates were run on a 10 % 
acrylamide gel, transferred to a PVDF membrane, and 
probed with either anti-phosphorylated STAT3 (1:1000), 
PI3K (1:1000), Akt (1:1000), PTEN (1:1000), p38 MAPK 
(1:1000), ERK1/2 (1:1000), SAPK/JNK (1:1000), β-Actin 
(1:1000) (Cell Signaling Tech. Inc., Danvers, MA, USA). 
Bands were visualized via chemiluminescence using 
horseradish peroxidase-conjugated secondary antibodies. 
Bands were quantified using β-actin as loading control by 
Bio-Rad Quantity One software (Bio-Rad, Mississauga, 
ON).
Animals
Six- to eight-week-old BALB/c female mice weighing 
18–20  g (Charles River, Montreal, QC) were randomly 
distributed into seven experimental groups: control, NBJ 
12.5  %, NBJ 25  %, NBJ 50  %, PEBP 12.5  %, PEBP 25  % 
and PEBP 50  %. Each experimental group consisted of 
8 mice housed in a controlled atmosphere (temperature 
22  ±  2  °C; humidity 55  ±  2  %) with a 12  h light/dark 
cycle. Mice were maintained and treated in accordance 
with the guidelines of the Canadian Council on Animal 
Care. The protocol (ME-289) was approved by the Ani-
mal Care Committee of University of Ottawa.
While mice in the control group received normal water, 
mice in NBJ- and PEBP-groups received either NBJ or 
PEBP, incorporated in their drinking water at three con-
centrations: 12.5, 25 and 50  % (v/v) respectively. After 
2  weeks of treatment, all mice received a subcutaneous 
injection of 4T1 cells (1400 cells/0.1  ml/mice) into the 
abdominal mammary gland fat pad. Three weeks after 
the inoculation, tumors and lungs were collected and 
weighed [32]. Mice consumed an average of 2.9  ml of 
juice each day and both blueberry juices were well toler-
ated and did not affect mice body weight.
Lung metastasis
Lungs were minced and dissociated in RPMI-1640 media 
containing 300 U/ml collagenase (Sigma), at 37  °C for 
15  min. After filtration through a 40  µm cell strainer 
(BD Biosciences), cells were collected and suspended 
in RPMI-1640 containing 10  % FBS (ATCC), penicillin/
streptomycin (0.05  mg/ml) and 60  μM 6-Thioguanine 
(Sigma). The cells were plated in 10-cm culture dishes 
(Corning) at 37 °C in a humidified atmosphere with 5 % 
CO2. After 14 days, the lung cells were fixed by methanol 
and stained with 0.03 % methylene blue solution. All blue 
colonies were counted, one colony representing one clo-
nogenic metastatic cell [32].
Statistical analysis
Statistical analysis of the data by ANOVA and Bonfer-
roni’s post hoc tests were performed using GraphPad 
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Prism software version 5.04 (San Diego, CA, USA). Sta-
tistical significance was set at p ≤0.05. Data are reported 
as mean ± SEM.
Results
Inhibition of breast cancer cell proliferation
At a concentration of 200  μM GAE, PEBP significantly 
inhibited the proliferation of 4T1, MDA-MB-231 and 
MCF-7 cancer cells by 34, 24 and 33  % respectively 
(Fig.  1), whereas the same concentration of NBJ only 
showed an inhibition of 32  % in 4T1 cell proliferation 
(Fig. 1a). No significant effects of NBJ were observed in 
MDA-MB-231 and MCF7 (Fig.  1b, c). Both PEBP and 
NBJ did not show any toxicity on the three cell lines at 
tested concentrations, as determined by an LDH assay 
(data not shown).
Reduction of motility and invasiveness potential
Both NBJ and PEBP at 150  μM Gallic Acid Equivalent 
(GAE) significantly reduced the invasive ability of 4T1 
and MDA-MB-231 (Fig.  2d, e). However, only PEBP 
exhibited an inhibitive effect on the motility of all three 
breast cancer cell lines (Fig.  2a–c). NBJ did not show 
any significant effect on cell motility as compared to the 
control.
Inhibition of mammosphere formation
PEBP significantly decreased the formation of mam-
mospheres in all three cell lines (Fig. 3), and nearly total 
inhibition was observed at 150 μM GAE of PEBP. A treat-
ment with the same concentration of NBJ only exhibited 
an inhibition of 75 % in MDA-MB-231 (Fig. 3b), whereas 
it significantly increased the formation of mammos-
pheres in 4T1 by 60 % (Fig. 3a).
Inhibition of IL‑6/STAT3/PI3K signaling pathway
A 6  h-treatment with NBJ in mammosphere formation 
conditions significantly elevated the secretion of IL-6 in 
all three cell lines (Fig. 3d–f), while PEBP did not induce 
any modification as compared to the control cells.
Moreover, PEBP significantly inhibited the phospho-
rylation of STAT3 and PI3K/Akt in all three cell lines. 
This inhibition started after a 6  h-treatment (Fig.  4a–i) 
and lasted up to 24 h (data not shown), whereas NBJ only 
decreased the phosphorylation of PI3K. Both PEBP and 
NBJ significantly enhanced the activity of PTEN in 4T1 
(Fig. 4j), but only PEBP increased PTEN phosphorylation 
in MDA-MB-231 and MCF-7 (Fig. 4k–l).
Alterations of MAPKs pathway
Starting from 1 h after the addition of PEBP, a significant 
inhibition of ERK1/2 phosphorylation was observed in 
4T1 and MCF-7 (Fig. 5a, c). PEBP also increased MAPK 
p38 and JNK/SAPK phosphorylation in all three cell 
lines. Their inhibited- or activated-state attainted the 
maximal level after 2 h of treatment and remained stable 
up to 24 h (Fig. 5d–i). NBJ did not show any significant 
modification of the three MAPKs family members.
Reduction of tumor growth, mammosphere formation 
and metastasis in vivo
As illustrated in Fig.  6, when administered chronically 
over a 5-week period, NBJ reduced tumor volume and 
weight in a dose-dependent manner. However, signifi-
cant effects were only observed in the NBJ  50  % group, 
whereas all three doses of PEBP-treated mice displayed 
significant delays of tumor growth (Fig.  6a, b). Moreo-
ver, the mammosphere formation from tumoral primary 
cells was significantly reduced exclusively in tumors of 
Fig. 1 PEBP suppressed the growth of mammary carcinoma cell lines. Proliferation of 4T1 (a), MDAMB‑231 (b), and MCF‑7 (c) cells after treatment 
with either 150 or 200 μM GAE (gallic acid equivalent) of either polyphenol‑enriched blueberry preparation (PEBP) or normal blueberry juice (NBJ) 
for 24 h. All values are means of 3 separated experiments ±SEM. *Denotes statistical significance at p ≤ 0.05 vs. control. **Denotes p ≤ 0.01 vs. 
control
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PEBP 50 %-treated animals (Fig. 6c). Similarly, the treat-
ment with PEBP significantly reduced the metastasis in 
lungs of PEBP-treated mice, while all of the other groups 
did not show a significant difference as compared to con-
trol animals (Fig. 6d).
Discussion
Chemoprevention is an important part of integrative and 
translational medicine in oncology. Naturally occurring 
compounds, such as polyphenols in fruits, are increas-
ingly recognized for their effects in controlling aberrant 
signaling pathways and inflammatory signals in CSCs. 
Our group has discovered that the fermented, probiotic-
like product PEBP greatly accentuates its antioxidant 
potential and endows it with novel anti-inflammatory 
[22], antidiabetic [24, 25] and neuroprotective [23] bio-
logical properties. The common mechanisms underlin-
ing the multiple beneficial effects of PEPB are probably 
related to its capability to modulate the activity of global 
regulators that are associated with cellular transforma-
tion and inflammation. In addition, biotransformations 
involving fermentation and catabolic breakdown have 
been suggested to enhance bioavailability [33].
In fact, PEBP was found to inhibit adipogenesis and 
increase glucose uptake in muscle cells and adipocytes 
[25] through the activation of the AMP-activated kinase, 
mimicking Metformin activities [34, 35]. Particularly, 
the anti-inflammatory effect of PEBP is pointing out to 
the blockade of the STAT3 pathways (essential in CSCs, 
and inflammation) and the activation of AMPK, which 
in turn inhibits MAPK downstream (essential in diabetes 
and cancer).
In addition, PEBP mimics Metformin anti-inflamma-
tory/antitumoral activities by inactivation of PI3K/AKT 
pathways. Metformin is now proposed as a major adjunct 
therapy in cancer with a powerful inhibitory effect on 
CSCs [36, 37]. This observation led us to further investi-
gate the effect of PEBP on CSCs.
The antiproliferative effect of PEBP was observed in all 
three breast cancer cell lines at 200  μM  GAE, whereas 
NBJ, at the same concentration, only had an effect in 4T1. 
NBJ did not show any antiproliferative effect in MDA-
MB-231 as previously reported [38, 39]. This might be 
due to the low tested-doses in our study. Moreover, PEBP 
significantly inhibited the motility of all three cancer 
cell lines, which prompted further investigation for its 
Fig. 2 PEBP decreased motility and invasiveness in gel invasion experiment. Cell mobility of 4T1 (a), MDAMB‑231 (b), and MCF‑7 (c) cells after 
treatment with 100 μM GAE (gallic acid equivalent) of either polyphenol‑enriched blueberry preparation (PEBP) or normal blueberry juice (NBJ) for 
24 or 48 h and cell invasion of 4T1 (d) and MDAMB‑231 (e) cells after treatment with either 100 or 150 μM GAE of PEBP or NBJ for 24 h. Contrast was 
enhance to better show cell motility. All values are means of 3 separated experiments ±SEM. *Denotes statistical significance at p ≤ 0.05 vs. control
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antimetastatic activity in  vivo. As expected, PEBP sig-
nificantly reduced metastasis potential to the lung when 
tested in a murine breast cancer model.
There is now substantial evidence that many cancers, 
including breast cancer, are driven by a cellular subpop-
ulation, identified as cancer stem cells, which mediate 
tumor metastasis and resistance to conventional thera-
pies. Therefore, controlling CSC growth in breast can-
cer is a possible avenue to prevent tumor development 
and metastasis. Thus, the investigation of PEBP-induced 
molecular mechanisms that mediate CSC growth was 
important to clarify its anticancer and anti-metastatic 
activities. Indeed, our data indicated that PEBP signifi-
cantly inhibited mammosphere formation in vitro. More-
over, its inhibitory effect was further confirmed by the 
reduction of ex  vivo mammosphere development from 
PEBP-treated animals.
Polyphenols naturally have multi-target actions/mech-
anisms, which explain their wide spectrum of biological 
activities [40]. Their anti-inflammatory property is the 
key factor in the interface between inflammation and 
neoplasia [41]. At the cross road of cancer and inflamma-
tion, the STAT3 and MAPK pathways have been reported 
as crucial for CSC growth and their acquired EMT char-
acteristics during metastasis [13, 42]. Depending on the 
cell type, the IL-6/STAT3-dependent pathways, such 
as the JAK/STAT [13], PI3K/AKT/NF-κB [43], or p38 
MAPK [44], can enhance tumor growth and refractori-
ness to chemotherapy [13]. Therefore, our studies were 
conducted to examine the involvement of these pathways 
in PEBP’s antitumor activities. We demonstrated that 
IL-6 production, as well as STAT3 and PI3K phospho-
rylation, were decreased in CSC culture after PEBP treat-
ment, when compared to the non-fermented control. 
Fig. 3 PEBP and NBJ decreased the formation of mammospheres in cell culture. Mammospheres formation of 4T1 (a), MDAMB‑231 (b), and MCF‑7 
(c) cells after treatment with either 100 or 150 μM GAE (gallic acid equivalent) of either polyphenol‑enriched blueberry preparation (PEBP) or normal 
blueberry juice (NBJ) for 4–7 days and IL‑6 production by 4T1 (d), MDAMB‑231 (e), and MCF‑7 (f) cells after treatment with 150 μM GAE of PEBP or 
NBJ for 6 and 24 h. All values are means of 4 separated experiments ±SEM. Bars that have no letter in common are significantly different from each 
other (p ≤ 0.05)
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Fig. 4 PEBP inhibited STAT3/PI3K/Akt signaling pathway. Phosphorylation of STAT3, PI3K, Akt, and PTEN in 4T1 (a, d, g, j), MDAMB‑231 (b, e, h, k), 
and MCF‑7 (c, f, i, l) mammospheres after treatment with 150 μM GAE (gallic acid equivalent) of either polyphenol‑enriched blueberry preparation 
(PEBP) or normal blueberry juice (NBJ) for 6 h. All values are means of 3 separated experiments ±SEM. Baseline represent the level of phosphoryla‑
tion present in cells not exposed to the mammospheres forming medium. *Denotes statistical significance at p ≤ 0.05 vs. control at 6 h
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Fig. 5 PEBP inhibited ERK1/2 but enhanced MAPKp38, and JNK signaling. Phosphorylation of ERK1/2, MAPK p38, and JNK in 4T1 (a, d, g), MDAMB‑
231 (b, e, h), and MCF‑7 (c, f, i) mammospheres after treatment with 150 μM GAE (gallic acid equivalent) of either polyphenol‑enriched blueberry 
preparation (PEBP) or normal blueberry juice (NBJ) for 2 h. All values are means of 3 separated experiments ±SEM. Baseline represent the level of 
phosphorylation present in cells not exposed to the mammospheres forming medium. * Denotes statistical significance at p ≤ 0.05 vs. control at 
2 h
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Although, polyphenols from blueberry have demon-
strated inhibitory activities on cancer cells via the con-
trol of inflammatory cytokines such as IL-6 [5], dramatic 
and biphasic increase of IL-6 occurs early in CSC cellular 
transformation [45], independently of STAT3 decrease. 
STAT3 signaling, an important inflammation-associated 
pathway in malignancies, has been recognized as a key 
therapeutic target to reduce tumor growth and metas-
tasis [15]. Several signal transduction pathways such as 
STAT3, PI3K/AKT/NF-κB cascade, p38/MAPK/ERK, or 
the AMPK pathways play an important role in inflamma-
tion-mediated response at all stages of cancer develop-
ment and refractoriness to chemotherapy [46]. Moreover, 
downstream effectors of the PI3K pathway include Akt, 
which is overexpressed in many cancer types and is 
associated with increased tumorigenicity [47, 48]. Our 
preliminary results showed that PEBP delayed the forma-
tion of CSCs in different types of cell culture and in vivo, 
through modulation of IL-6/STAT3, the PTEN/PI3K/
AKT axis, and ERK/p38 in MAPK signaling pathways, 
which are all central nodes in CSC signaling and homeo-
stasis [49] (Figs. 3, 5). We have demonstrated that STAT3, 
AKT, and PI3K are decreased, PTEN (a tumor suppres-
sor gene upregulated by p53) is increased in a non-cell 
type dependent manner, and ERK1/2 was significantly 
inhibited in 4T1 and MCF7 (Fig. 5). In MAPK pathways, 
ERK1/2 is the most relevant to breast cancer. Increased 
expression of ERK1/2 was recently reported as driving 
endocrine resistance and breast cancer progression in an 
obesity-associated experimental model [50]. In fact, both 
PEBP and NBJ inhibited the phosphorylation of PI3K. 
These findings are consistent with previous reports, 
which attributed the inhibition of PI3K activity to the 
anticancer effects of blueberry [6, 38]. In our study, PEBP 
and NBJ also enhanced the activity of PTEN, an upstream 
inhibitor protein of PI3K, possibly via the inhibition of 
miRNA-21 expression [51]. These alterations, unfound 
with NBJ, could be exerted by the novel compounds that 
were produced during biotransformation and acted in 
concert on different types of receptors.
Fig. 6 Antitumoral effects of PEBP in BALB/c mice model with 4T1 cell challenge. Tumor volume (a), tumor weight (b), mammospheres forma‑
tion from primary tumor cells (c) and metastasis present in lungs (d) of mice that received a 2‑week pre‑treatment and a 3‑week post‑inoculation 
treatment with either polyphenol‑enriched blueberry preparation (PEBP) or normal blueberry juice (NBJ) incorporated in drinking water at con‑
centrations of 12.5 % (NBJ 12.5 % and PEBP 12.5 %), 25 % (NBJ 25 % and PEBP 25 %), and 50 % (NBJ 50 % and PEBP 50 %). All values are means of 2 
separated experiments ±SEM (n = 16). *Denotes statistical significance at p ≤ 0.05 vs. control
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Treatment with PEBP rapidly increased p38-MAPK- 
and JNK- phosphorylation, which significantly reached 
its highest level at 2 h, and remained elevated for up to 
24 h. PEBP reduced ERK1/2 phosphorylation in the same 
kinetic and cell-type independent manner. Modifica-
tions in MAPK family enzymes might contribute to the 
abolition of stem cell growth afforded by PEBP. Indeed, 
prolonged activations of JNK and MAPKp38 and/or inhi-
bition of ERK1/2 induced apoptosis in most cancer cell 
lines [52–55]. The mechanisms by which PEBP modi-
fied MAPKs’ activities are unknown. In addition, PEBP-
induced alterations of upstream MAPK members might 
inhibit the downstream STAT3/PI3K/Akt signaling, indi-
cating an extensive cross-talk and interplay between the 
MAPK cascade and STAT3 pathways.
We further confirmed the in vivo anticancer and anti-
metastatic potential of PEBP using the 4T1-induced 
breast cancer model in BALB/c mice. The 4T1 tumor is 
highly tumorigenic and invasive and, unlike most tumor 
models, can spontaneously metastasize from the primary 
tumor in the mammary gland to multiple distant sites 
[56, 57].
Chronic administration of PEBP via incorporation in 
drinking water significantly reduced tumor volume and 
breast cancer stem cell development derived from the 
tumor. This diminution supports the low count of metas-
tasis in lungs of PEBP-treated animals. Especially, PEBP 
anticancer and antimetastatic effects were observed at 
a therapeutic dose as low as 12.5 %, which, according to 
dose translation from animal to human using body sur-
face area, corresponds to 1.2 cups of juice per day for 
humans [58]. In contrast, NBJ at the same dose did not 
show any significant effect. NBJ could show a decrease 
in tumor size and weight only at the dose of 50 %, which 
represents a substantial consumption of blueberry juice 
for humans. These results are consistent with findings 
from previous studies, which reported that feeding mice 
with blueberry extracts or whole fruit powder has an 
impact on inflammation and could delay tumor growth 
[6, 38, 59]. However, NBJ failed to achieve the reduc-
tion of breast cancer stem cells and metastasis observed 
with PEBP. Nonetheless, the process of preparing PEBP, 
which greatly increases the content in total phenolic 
compounds, could clarify its effectiveness at a low thera-
peutic dose as compared to NBJ. Furthermore, the novel 
antimetastatic potential of PEBP could be explained by 
the change of phenolic composition from NBJ to PEBP 
during the biotransformation process. Indeed, the bio-
transformation of blueberry juice not only increases its 
phenolic content, but also produces novel compounds 
[8]. One interesting possibility is that these novel com-
pounds may possess more potent anticancer and anti-
metastatic properties that could have contributed to 
the observed reduction in tumor size and metastasis, 
as opposed to components of NBJ. In addition, the bio-
transformation process has probably broken down long 
polyphenol chains, which are poorly absorbed into gas-
tro-intestinal tracts, increasing their bioavailability, and 
rendering PEBP highly functional [60].
Conclusion
The results of the present study demonstrate that poly-
phenol-enriched blueberry preparation potently reduced 
the tumor growth and metastasis in mice. We have dem-
onstrated that repression of breast Cancer Stem Cells 
(CSCs) by fermented blueberry supports a diet-medi-
ated targeting of CSCs. We have provided evidence that 
PEBP selectively inhibits the inflammatory signature in 
CSCs through signaling pathways linked to the main-
tenance stemness and metastasis. The mechanisms of 
action involve, at least in part, alterations in the MAPKs 
cascade and inhibition of the STAT3 signaling pathway, 
involved in inflammatory pathways. The results con-
vincingly demonstrated that PEBP, indeed, holds great 
promise as a chemopreventive agent and may represent 
a novel complementary therapy against breast cancer and 
metastasis. Conclusively, the prospective modulation of 
CSCs by nutrition will probably mark a major advance 
in preventing breast cancer and further optimizing the 
management of this significant disease. It is an important 
approach in translational medicine for specific integra-
tive therapies that can be recommended as evidence-
based supportive care for cancer patients.
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